Related Experiment Video

Updated: Jun 3, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Role of the RAS in pancreatic cancer

Sin Ting Lau1, Po Sing Leung

  • 1School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

Current Cancer Drug Targets
|March 15, 2011
PubMed

Insights

The renin-angiotensin system (RAS) promotes pancreatic cancer growth. Blocking RAS with drugs like AT1R blockers or ACE inhibitors may offer new treatments for pancreatic cancer.

Area of Science:

  • Oncology
  • Cardiovascular Biology
  • Endocrinology

Background:

  • The renin-angiotensin system (RAS) regulates blood pressure and fluid balance.
  • Angiotensin II (Ang II), a key RAS peptide, influences various tissue functions.
  • Local RAS activation is implicated in pancreatic cancer progression.

Purpose of the Study:

  • To review the role of the RAS in pancreatic cancer.
  • To explore the therapeutic potential of RAS blockade in pancreatic cancer treatment.

Main Methods:

  • Literature review of studies on RAS in pancreatic cancer.
  • Analysis of experimental data from cell and animal models.
  • Discussion of pharmacological RAS blockade strategies.

Main Results:

  • Angiotensin II (Ang II) promotes pancreatic tumor growth and angiogenesis via AT1R.
  • Upregulation of AT1R and ACE in pancreatic cancer enhances Ang II activity.
  • RAS blockade shows potential in inhibiting tumor growth, angiogenesis, and metastasis.

Conclusions:

  • The RAS plays a significant role in pancreatic cancer development and progression.
  • Targeting the RAS with blockers offers a promising therapeutic strategy for pancreatic cancer.
  • Further research into RAS-targeted drugs could lead to effective pancreatic cancer treatments.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...